This study is the first to demonstrate that lower levels of CYP26A1 expression are significantly associated with the risk of oral and pharyngeal cancers, showing a relationship between the levels of CYP26A1 and SNP polymorphism. This evidence concerns the gene CYP26A1 and pharynx cancer.